张阳盛
中国区HEOR&RWE总监
专长:
Dr. Ivan Tjong-A-Hung is a business leader for Health Economic and Outcomes Research & Real-World Evidence (HEOR and RWE) with over 30 years of experience in the Healthcare Industry. At EVERSANA China, he leads the business development activities and is building an experienced dedicated team for HEOR & RWE services.
在加入EVERSANA之前，Ivan曾在辉瑞、赛诺菲和雅典娜医疗咨询公司工作，工作地遍及荷兰、法国和中国。他在市场营销、医疗事务、研发、咨询以及HEOR和RWE的设计和应用、品牌传播、医药营销和销售方面都有着丰富的经验。
Ivan拥有荷兰乌得勒支大学的医学博士学位和英国曼彻斯特大学金融专业的工商管理硕士学位。他还完成了英国威尔士大学的制药医学研究生课程。”
Articles by 张阳盛
Matching-Adjusted Indirect Comparison (MAIC): An Established Methodology for Comparing Treatment Efficacies Across Trials
In the realm of comparative effectiveness research (CER), decision-makers often face challenges when attempting to compare treatment efficacies due to limited availability of comparative data, especially for new therapies. This white paper introduces the Matching-Adjusted Indirect Comparison (MAIC) methodology as a powerful technique for addressing these evidence gaps. MAIC combines individual patient data (IPD) from […]